International Journal of Hematology

Article	Citations
Differences in longitudinal growth patterns of children and adolescents with transfusion-dependent hemoglobin E/β-thalassemia and those achieving successful hematopoietic stem-cell transplantation	91
Comparison between filgrastim biosimilar and filgrastim original for the management of neutropenia after salvage chemotherapy for malignant lymphoma	58
Acute suppression of translation by hyperthermia enhances anti-myeloma activity of carfilzomib	56
Carcinocythemia diagnosed on peripheral blood clot sections	37
NOVEL-1st: an observational study to assess the safety and efficacy of nilotinib in newly diagnosed patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase in Taiwan	35
Real-world treatment patterns and clinical outcomes in patients with AML in Japan who were ineligible for first-line intensive chemotherapy	27
Post-transfusion purpura and adult primary thrombocytopenia	26
Coexpression of natural killer cell antigens by T-cell large granular lymphocytes in hydroa vacciniforme lymphoproliferative disorder and the involvement of Vδ1 + epithelial-type γδT cells	26
Asciminib in patients with newly diagnosed chronic myeloid leukemia: results from the Japanese subgroup of ASC4FIRST	25
Acute myeloid leukemia with NUP98::RARG rearrangement: a case report and review of the relevant literature	25
Changes in coagulation potential over time after administration of recombinant activated factor VII in an emicizumab-treated hemophilia A patient with inhibitors	24
Advances in immune microenvironment profiling during multiple myeloma progression and therapy	23
IBRORS-MCL study: a Spanish retrospective and observational study of relapsed/refractory mantle-cell lymphoma treated with ibrutinib in routine clinical practice	23
WT1-guided pre-emptive therapy after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia	21
Real-world toxicity and effectiveness of ixazomib, lenalidomide, and dexamethasone in Korean patients with relapsed and/or refractory multiple myeloma	21
CEBPA mutations in acute myeloid leukemia: implications in risk stratification and treatment	21
EVI1 upregulates PTGS1 (COX1) and decreases the action of tyrosine kinase inhibitors (TKIs) in chronic myeloid leukemia cells	20
Ex vivo manufacturing of platelets: beyond the first-in-human clinical trial using autologous iPSC-platelets	20
Hexokinase II expression as a prognostic marker in diffuse large B-cell lymphoma: pre- and post-rituximab era	19
Tazemetostat for relapsed/refractory B-cell non-Hodgkin lymphoma with EZH2 mutation in Japan: 3-year follow-up for a phase II study	18
Isolated thrombosis after COVID-19 vaccination: case series	18
Reduced incidence of hemophagocytic lymphohistiocytosis in Japan during the COVID-19 pandemic	17
Treatment trends and risks of corticosteroid use in adult primary immune thrombocytopenia: a claims database study in Japan	17
Real-world data of AML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11)	17
Some key considerations regarding the design and evaluation of high-throughput sequencing-based biallelic chimerism assays	16

Progression to B acute lymphoblastic leukemia in 8p11 myeloproliferative syndrome with t(6;8)(q27;p12)	15
Risk factors and remaining challenges in the treatment of acute promyelocytic leukemia	15
Possible prognostic impact of WT1 mRNA expression at day + 30 after haploidentical peripheral blood stem cell transplantation with posttransplant cyclophosphamide for patients with myeloid neoplasm: a	15
Efficacy and safety of recombinant porcine factor VIII in Japanese patients with acquired hemophilia A	15
Sustained remission after cord blood transplantation for breast cancer with lung metastases and myelodysplastic syndrome	14
Chemotherapy-induced aseptic thrombophlebitis with an air bubble in the thrombus	14
Multicenter evaluation of the addition of eltrombopag to immunosuppressive therapy for adults with severe aplastic anemia	14
BRD9 depletion-mediated ALOX5 upregulation via chromatin dysregulation induces ferroptosis in SF3B1-mutant hematopoiesis	13
Three atypical BCR/ABL transcripts detected simultaneously in a Philadelphia-positive acute lymphoblastic leukemia patient showing resistance to tyrosine kinase inhibitors	13
Lymphoma during pregnancy in Japan: a multicenter retrospective cohort study	13
Effects of human herpesvirus 6B reactivation on cognitive function in cord blood transplant recipients: a prospective multicenter study	13
SPAG6 regulates cell proliferation and apoptosis via TGF-β/Smad signal pathway in adult B-cell acute lymphoblastic leukemia	13
Real-world bleeding outcomes and product utilization in people with severe-type hemophilia A before and after switching to extended half-life rFVIIIFc prophylaxis therapy	13
Humoral immunity after hematopoietic stem cell transplantation: evaluation by B-cell receptor repertoire analysis	13
A case report of a truncated ABL1 mutation in 2 cases with Philadelphia chromosome-positive B cell precursor acute lymphoblastic leukemia	13
HLA haploidentical stem cell transplantation from HLA homozygous donors to HLA heterozygous donors may have lower survival rates than haploidentical transplantation from HLA heterozygous donors to HLA	13
Primary pancreatic diffuse large B-cell lymphoma, appearing as an asymptomatic bulky mass with the duct-penetrating sign	13
JSH practical guidelines for hematological malignancies, 2023: II. lymphoma—overview	12
Evolution and optimization of therapies for acute lymphoblastic leukemia in infants	12
Efficacy of polatuzumab vedotin versus conventional chemotherapy in relapsed or refractory diffuse large B-cell lymphoma	12
Current and emerging therapeutic strategies in adult T-cell leukemia–lymphoma	12
Bone marrow ring sideroblasts in hematological diseases: an analysis of consecutive 1300 samples in a single institution	11
Comparative inhibitory effects of bepotastine and diphenhydramine on rituximab-induced infusion reactions	11
Retrospectively diagnosed autoimmune VWF deficiency in a patient with repeated hemorrhagic events after two common colds	11
Real-world effectiveness of ixazomib, lenalidomide and dexamethasone in Asians with relapsed/refractory multiple myeloma	11
Guest Editorial: what can be done to improve cancer immunotherapies?	11
Validation of an algorithm for identifying patients with febrile neutropenia: an epidemiological study using real-world data in Japan	11
Ten years’ experience in prenatal diagnosis of α-thalassemia in a municipal hospital and retrospective analysis of ultrasonic abnormalities	11
Romidepsin-induced durable remission for relapsed nodal peripheral T-cell lymphoma with T follicular helper phenotype after allogeneic hematopoietic cell transplantation	10
Effect of delivery mode on postnatal platelet count dynamics in neonates born to mothers with immune thrombocytopenia	10
Diagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) in Japan 2023	10
Phase 2 study of combination chemotherapy with bortezomib in children with relapsed and refractory acute lymphoblastic leukemia	10
Correlation of ex vivo and in vivo ammonia production with L-asparaginase biological activity in adults with lymphoid malignancies	10
Dose optimization of tyrosine kinase inhibitor therapy in chronic myeloid leukemia	10
Letter to the Editor: Very low-dose antithymocyte globulin (thymoglobulin) is effective for steroid-refractory acute graft-versus-host disease involving the skin or gut after allogeneic hematopoietic	10
Maintenance therapy after allogeneic hematopoietic stem cell transplantation for patients with multiple myeloma	10
DLI-induced remission in recurrent EBV-associated T/NK-cell lymphoproliferative disease following HSCT: a case report	10
Correction to: A phase I study of inotuzumab ozogamicin as a single agent in pediatric patients in Japan with relapsed/refractory CD22-positive acute lymphoblastic leukemia (INO-Ped-ALL-1)	10
Combined tumor necrosis factor-α (−308 G/A) and tumor necrosis factor-β (+ 252 A/G) nucleotide polymorphisms and chronicity in Egyptian children with immune thrombocytopenia	10
Assay variables and early clinical evaluation of low-angle light scattering for platelet function analysis	10
Nodal mature plasmacytoid dendritic cell proliferation mimicking lymphoma in a patient with CALR-mutated myelofibrosis	10
Association between the pharmacokinetics of rabbit anti-thymocyte globulin and acute graft-versus-host disease in patients who received haploidentical hematopoietic stem cell transplantation	9
Detection of Talaromyces marneffei in a HIV-infected patient from peripheral blood observation through Sysmex XN WNF/WNR channels	9
Improvement of immune thrombocytopenia with imatinib therapy following chronic myeloid leukemia	9
Clinical and genetic features of Japanese cases of MDS associated with VEXAS syndrome	9
Efficacy and safety of ropeginterferon alfa-2b in Japanese patients with polycythemia vera: an open-label, single-arm, phase 2 study	9
Resilient T-cell responses in patients with advanced cancers	9
Therapy-related acute myeloid leukemia with inv(16)(p13.1q22)	9
Influence of FOXP3 single-nucleotide polymorphism after allogeneic hematopoietic stem cell transplantation	9
Retrospective analysis of treatment discontinuation in minimal residual disease negative multiple myeloma	9

Skin complications during iron chelation therapy for beta-thalassemia: overview and treatment approach	9
An adult case of refractory autoimmune neutropenia after liver transplantation	9
Multiple myeloma with high-risk cytogenetics and its treatment approach	9
Age-related variation in coagulation factors in non-valvular atrial fibrillation patients receiving direct oral anticoagulants	8
Transplantation outcomes of TP53-mutant AML and MDS: a single transplantation center experience of 63 patients	8
Sarcopenia and clinical outcomes in lymphoma and multiple myeloma patients receiving hematopoietic cell transplantation: a systematic review and meta-analysis	8
A retrospective survey of patients who discontinued participation in the JPLSG HLH-2004 clinical trial	8
Asciminib in Patients With CML-CP Previously Treated With ≥ 2 Tyrosine Kinase Inhibitors: 96-Week Results From the Japanese Subgroup Analysis of the ASCEMBL Study	8
Auer rods in mature granulocytes in peripheral blood	8
Clinical features of immature leukemias in children	8
Prevention of venous thromboembolism in pregnant women with congenital antithrombin deficiency: a retrospective study of a candidate protocol	8
Long-term efficacy and safety profile of splenectomy for pediatric chronic immune thrombocytopenia	8
COVID-19 omicron variant outbreak in a hematopoietic stem cell transplant unit	8
A phase I study of inotuzumab ozogamicin as a single agent in pediatric patients in Japan with relapsed/refractory CD22-positive acute lymphoblastic leukemia (INO-Ped-ALL-1)	8
Tumor lysis syndrome in induction therapy for acute myeloid leukemia before the rasburicase era	8
Introduction of the T315I gatekeeper mutation of BCR/ABL1 into a Philadelphia chromosome-positive lymphoid leukemia cell line using the CRISPR/Cas9 system	8
Myeloid leukemoid reaction after initial azacitidine therapy for chronic myelomonocytic leukemia	8
A novel stroma-dependent leukemia cell line from a patient with mixed-phenotype acute leukemia with Ph chromosome and PAX5 mutation	8
Management of inpatient chimeric antigen receptor T-cell therapy for relapsed/refractory B-cell malignancies: an analysis using the Japanese Diagnosis Procedure Combination database	7
Development of a blood test-based predictive scoring tool for treatment response in chronic myeloid leukemia	7
Pseudo-Chediak–Higashi inclusions and Auer rods in a case of therapy-related acute monocytic leukemia	7
Management of lymphoma-associated chylothorax by interventional radiology and chemotherapy: a report of five cases	7
Correction: Efficacy and safety of equine anti-thymocyte immunoglobulin (eATG) in three Japanese patients with moderate to very severe aplastic anemia: a case series	7
Leukemic-phase mucosa-associated lymphoid tissue lymphoma	7
Clinicopathological characteristics associated with the engraftment of patient lymphoma cells in NOG mice	7
Sequential occurrence of BCR::ABL1-negative MPN and CML and vice versa: results from a real world cohort	7
Recent advances in the diagnosis and treatment of pediatric acquired aplastic anemia	7
Prognostic impacts of serum levels of C-reactive protein, albumin, and total cholesterol in patients with myelodysplastic syndromes	7
Japanese and French translation and linguistic validation of a patient-reported outcome tool to assess quality of life in patients with Immune Thrombocytopenia (ITP): the ITP Life Quality Index (ILQI)	7
Clinical significance of total nucleated cell count in bone marrow of patients with acute lymphoblastic leukemia who underwent allogeneic hematopoietic stem cell transplantation	7
Prophylactic or preemptive tyrosine kinase inhibitor therapy after allogeneic hematopoietic cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia	7
Prognostic significance of age at diagnosis and preceding infection varies across age groups in childhood immune thrombocytopenia	7
Outcomes of elranatamab in relapsed/refractory multiple myeloma: prognostic impact of monocyte count, MyCARe, and R2-ISS	7
Epidemiological survey of potential familial myelodysplastic syndromes/acute myeloid leukemia in Hawaii	7
Venetoclax and azacitidine in combination with homoharringtonine, cytarabine, and aclarubicin for salvage therapy of relapsed/refractory T cell acute lymphoblastic leukemia	7
Frontiers in pathophysiology and management of thrombotic thrombocytopenic purpura	7
Integrin β5 and β7 expression in lenalidomide-resistant multiple myeloma cells	7
Longitudinal dynamic changes in factor VIII inhibitor titers in patients with hemophilia A and inhibitors receiving emicizumab prophylaxis	7
COVID-19 microthrombosis: unusually large VWF multimers are a platform for activation of the alternative complement pathway under cytokine storm	7
A phase 2 trial of VRD induction for transplant-eligible Japanese patients with newly diagnosed multiple myeloma	7
Neuropeptide TIP39 induces autophagy in PTH2 receptor-positive myeloid neoplasms	6
Severe infections and renal dysfunction during immunosuppressive therapy with cyclosporine A for aplastic anemia	6
Characterization of congenital factor XII deficiency in Taiwanese patients: identification of one novel and one common mutation	6
A rare case of concurrent metastatic breast cancer and follicular lymphoma diagnosed by lymph node biopsy: a case report	6
Langerhans cell histiocytosis with mesenteric involvement successfully treated with trametinib: a rare cause of small intestine obstruction	6
Bilateral development of biclonal ocular adnexal marginal zone lymphoma at a 2-year interval	6
Recent advances in understanding the biology of follicular lymphoma	6
Clinical practice guidelines for management of disseminated intravascular coagulation in Japan 2024. Part 1: sepsis	6
Real-world safety profile of eculizumab in patients with paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, or generalized myasthenia gravis: an integrated analysis of post-marke	6
Hematopoietic cell transplantation in pediatric EB virus-associated hemophagocytic lymphohistiocytosis	6
Clinical characteristics of late-onset interstitial pneumonia after allogeneic hematopoietic stem cell transplantation	6
Longer-than-expected survival in TP53-mutated MDS with der(5;19)(p10;q10): lessons from three cases	6
Expansion effect of romiplostim on hematopoietic stem and progenitor cells versus thrombopoietin and eltrombopag	6
Severe short-term adverse events in related bone marrow or peripheral blood stem cell donors	6
A case of posttransplant isolated extramedullary relapse of acute lymphoblastic leukemia achieving durable treatment-free remission with blinatumomab and donor lymphocyte infusion	6
FLT3 targeting in the modern era: from clonal selection to combination therapies	6
Dysregulated hemostasis in acute promyelocytic leukemia	6
The mutual crosstalk between iron and erythropoiesis	6
Outcome of chemotherapy dose reduction in overweight Japanese children with acute lymphoblastic leukemia	6
TBI, etoposide, and cyclophosphamide conditioning for intermediate-risk relapsed childhood acute lymphoblastic leukemia	6
Venetoclax with CAG regimen for early T-cell precursor acute lymphoblastic leukemia: a case report and literature review	6
Cardiovascular toxicity from tyrosine kinase inhibitors in chronic myeloid leukemia with severe dilated cardiomyopathy	6
Ex vivo expansion and activation of Vγ9Vδ2 T cells by CELMoDs in combination with zoledronic acid	6
Modeling and therapeutic targeting of t(8;21) AML with/without TP53 deficiency	6
Correction to: Evolution in the management of chronic lymphocytic leukemia in Japan: should MRD negativity be the goal?	6
JSH practical guidelines for hematological malignancies, 2023: leukemia-2—acute promyelocytic leukemia (APL)	6
A retrospective analysis of autologous stem cell transplantation conditioning with reduced-dose busulfan/thiotepa for patients with central nervous system lymphomas at a single institution	6
MYC-rearranged blastic plasmacytoid dendritic cell neoplasm with immunoblastoid features	5
JSH practical guidelines for hematological malignancies, 2023: II. Lymphoma 4. Mantle cell lymphoma (MCL)	5
HLA-haploidentical T-cell receptor αβT/B-cell-depleted stem cell transplantation for Fanconi anemia	5
Correction: JSH practical guidelines for hematological malignancies, 2023: leukemia-2—acute promyelocytic leukemia (APL)	5
A Phase 1/2 study of teclistamab, a humanized BCMA × CD3 bispecific Ab in Japanese patients with relapsed/refractory MM	5
Recent advances in AML with mutated NPM1	5
Bosutinib-induced lung injury: a report of two cases and literature review	5
Thiotepa-based high-dose chemotherapy with autologous stem cell transplantation for neurolymphomatosis	5
Septic shock caused by Capnocytophaga canimorsus in a patient with heterozygous Pelger-Huët anomaly	5
Erythroblast predominance without CD41/cyCD41-positive blasts predicts favorable prognosis in patients with myelodysplastic syndromes and acute myeloid leukemias treated with azacitidine	5
Thrombophagocytosis by myeloid blasts in acute myeloid leukemia with biallelic CEBPA mutations	5
Burkitt in disguise: clonal transformation of incidentally detected gallbladder diffuse large B-cell lymphoma in a liver transplant recipient	5
New onset of hypomegakaryocytic thrombocytopenia with the potential for progression to aplastic anemia after BNT162b2 mRNA COVID-19 vaccination	5

Mature T-cell and NK-cell lymphomas: updates on molecular genetic features	5
Guest editorial: recent progress in pediatric leukemia	5
FNAIT pathogenesis determined by serial analysis of three subsequent pregnancies of a woman with severe fetal and neonatal alloimmune thrombocytopenia (FNAIT) with anti-HPA-4b and anti-HPA-5b alloanti	5
Reduced OTUD7B expression correlates with poor prognosis in PTCL via non-canonical NF-κB	5
A phase 2 clinical trial of luspatercept in non-transfusion-dependent patients with myelodysplastic syndromes	5
Novel immunotherapies in multiple myeloma	5
Post-marketing surveillance of the safety and effectiveness of nivolumab for classic Hodgkin lymphoma in Japan	5
Stem cell regulation and dynamics in myeloid malignancies	5
A phase 1/2 study of gilteritinib in combination with chemotherapy in newly diagnosed patients with AML in Asia	5
Prognostic model for relapsed/refractory transplant-ineligible diffuse large B-cell lymphoma utilizing the lymphocyte-to-monocyte ratio	5
Massive pleural effusion as the initial presentation of Waldenström macroglobulinemia: rare extramedullary involvement	5
Clinical diagnostic accuracy of respiratory failure in critically ill hematopoietic stem cell transplant patients	5
Spontaneous regression of multiple solitary plasmacytoma harboring Epstein–Barr virus: a case report and literature review	5
Pneumatic tube transport-induced pseudohyperkalemia in patients with extreme leukocytosis: a retrospective study from a single medical center	5
Heme as a differentiation-regulatory transcriptional cofactor	5
Decreased incidence of acute immune thrombocytopenia in children during the COVID-19 pandemic	5
In vitro evaluation of global coagulation potential of emicizumab and warfarin using rotational thromboelastometry	5
NK-cell post-transplant lymphoproliferative disease successfully treated by second allogenic hematopoietic stem cell transplantation in chronic active Epstein–Barr virus infection	5
A case of late-onset sinusoidal obstruction syndrome diagnosed histologically before meeting diagnostic criteria	5
Reply to the Dr. Murphy’s comment	5
Identification and functional analysis of three novel genetic variants resulting in premature termination codons in three unrelated patients with hereditary antithrombin deficiency	5
VEXAS syndrome	5
Successful autologous stem cell transplantation in a case of central nervous system relapse of diffuse large B-cell lymphoma with concurrent polycythemia vera	4
Efficacy of alternate day versus daily oral iron therapy in children with iron deficiency anemia: a randomized controlled trial.	4
JSH Practical Guidelines for Hematological Malignancies, 2023: II. Lymphoma—2. Marginal zone lymphoma: MZL (extranodal marginal zone lymphoma: EMZL [extranodal marginal zone lymphoma of mucosa associa	4
Minimal residual disease detection by mutation-specific droplet digital PCR for leukemia/lymphoma	4
Long-range and real-time PCR identification of a large SERPINC1 deletion in a patient with antithrombin deficiency	4
Effect of conditioning intensity on late complications in AYA who underwent allogeneic HCT during childhood	4
Comparison of disease and risk classifications of AML before and after incorporation of NGS analysis of bone marrow samples	4
Measurement of serum hepcidin-25 by latex agglutination in healthy volunteers and patients with hematologic disorders	4
Development of TCR-T cell therapy targeting mismatched HLA-DPB1 for relapsed leukemia after allogeneic transplantation	4
Outcomes of salvage haploidentical transplantation using posttransplant cyclophosphamide for graft failure following allogeneic hematopoietic stem cell transplantation	4
Ropeginterferon-α2b discontinuation after long-term exposure: four cases from a single institution	4
A phase 1/2 study of NS-87/CPX-351 (cytarabine and daunorubicin liposome) in Japanese patients with high-risk acute myeloid leukemia	4
Therapeutic impact of mesenchymal stem cells on idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation	4
Genome–epigenome crosstalk in T-cell lymphomas: from maps to mechanisms	4
Association between early corticosteroid administration and long-term survival in non-infectious pulmonary complications after allogeneic hematopoietic stem cell transplantation	4
Correction: Real‑world safety profile of eculizumab in patients with paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, or generalized myasthenia gravis: an integrated analysis o	4
A successful control of cardiac amyloidosis by idecabtagene vicleucel in a patient with relapsed and refractory multiple myeloma: a case report and literature review	4
Retrospective nationwide survey of pediatric RDD in Japan: a high prevalence of mutations in the kinase pathway genes	4
JSH practical guidelines for hematological malignancies, 2023 III. Myeloma 2. Related disorders of multiple myeloma	4
Impact of center volume on acute graft versus host disease in allogeneic stem cell transplant recipients	4
Role of JAK inhibitors in myeloproliferative neoplasms: current point of view and perspectives	4
Bringing mass spectrometry into the care of patients with multiple myeloma	4
Effectiveness of posaconazole as primary prophylaxis in allogeneic hematopoietic stem cell transplantation	4
JSH practical guidelines for hematological malignancies, 2023: II. Lymphoma5. Diffuse large B-cell lymphoma, not otherwise specified (DLBCL, NOS)	4
Downregulation of HLA class II is associated with relapse after allogeneic stem cell transplantation and alters recognition by antigen-specific T cells	4
Front-line fludarabine-cyclophosphamide-rituximab (FCR) in 110 patients with chronic lymphocytic leukaemia (CLL): real-life experience with long-term outcomes, toxicities and responses to second-line	4
Favorable outcomes of allogeneic hematopoietic stem cell transplantation with fludarabine–bendamustine conditioning and posttransplantation cyclophosphamide in classical Hodgkin lymphoma	4
Blasts engulfing erythrocytes: an unusual morphological finding in adult early T-precursor acute lymphoblastic leukemia	4
Knockdown of the Shwachman-Diamond syndrome gene, SBDS, induces galectin-1 expression and impairs cell growth	4
Anakinra for the treatment of adult secondary HLH: a retrospective experience	4
Long-term immunity to measles and rubella after vaccination in adult allogeneic hematopoietic stem cell transplant recipients	4
Histological confirmation and radiotherapy facilitate continuation of epcoritamab in a patient with tumor flare reaction	4
Pulmonary hypertension is associated with poor cardiovascular and hematologic outcomes in patients with myeloproliferative neoplasms and cardiovascular disease	4
A retrospective analysis of clinicopathological and genetic features of synchronous CNS and systemic DLBCL at diagnosis	4
Characteristics and literature review of ETV6::ABL1 fusion gene-positive acute myeloid leukemia	4
Correction: JSH practical guidelines for hematological malignancies, 2023: I. Leukemia-1. Acute myeloid leukemia (AML)	4
Platelet and large platelet ratios are useful in predicting severity of COVID-19	4
Pretransplant hepatomegaly is linked to relapse in patients with leukemia and myelodysplastic syndrome not in remission	4
Factor XII deficiency: a clinical and molecular genetic study	4
Very early death within 30 days after diagnosis in patients with acute myeloid leukemia	4
Multifocal osteonecrosis after stem cell transplantation	4
Vedolizumab for children with intestinal graft-versus-host disease: a case report and literature review	4
Epigenetics in lymphocyte and lymphoma: EZH2 as an easy-to-access therapeutic target?	4
Comprehensive assessment of DeVIC therapy for relapsed or refractory diffuse large B-cell lymphoma	4
Japanese phase Ib study of the oral PI3K-δ and -γ inhibitor duvelisib in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma	4
Impact of muscle loss in children with hematologic malignancies undergoing allogeneic hematopoietic cell transplantation	4
Safety and antitumor activity of copanlisib in Japanese patients with relapsed/refractory indolent non-Hodgkin lymphoma: a phase Ib/II study	4
Plasma proteomics associated with autoimmune coagulation factor deficiencies reveals the link between inflammation and autoantibody development	4
Post-remission measurable residual disease directs treatment choice and improves outcomes for patients with intermediate-risk acute myeloid leukemia in CR1	4
Tertiary prophylaxis with extended half-life factor prophylaxis: a model to reduce disability in low- and middle-income countries	4